Personalized Oncology: Circulating Cancer Cells Before, During, and After Therapy
Tuesday, 03.03.2026, 8.00pm (CET), English
at 8.00pm(CET-Berlin)
at 7:00pm(GMT-London)
Personalized oncology aims to tailor cancer therapies to the individual patient, maximizing therapeutic efficacy while minimizing side effects. A key approach in this context is the analysis of circulating cancer cells in the blood, which can provide valuable insights into tumor activity, treatment response, and the risk of disease recurrence. In this webinar, we will demonstrate how maintrac® and stemtrac® can be applied throughout the entire course of therapy: before treatment to support individualized treatment decisions, during therapy for therapy monitoring and early assessment of treatment response, and after therapy for ongoing monitoring, analysis of therapy-relevant tumor cell characteristics, and early detection of potential relapse. In addition, we will present current findings from our research and place them in a clinical context.
Speaker: Prof. Dr. med. Katharina Pachmann
We look forward to your participation and scientific exchange. You are welcome to ask questions on current topics, discuss clinical cases with Prof. Dr. Pachmann, and exchange ideas with colleagues in your field. The maintrac® Online Forum will be conducted via Zoom. You can find the privacy policy here. By joining the maintrac® Online Forum, you agree to the privacy policy.
Your team at Pachmann GmbH & Co. KG
Access to the meeting will be opened 30 minutes prior to the start of the Online Forum
Join here for the maintrac® Online Forum.
Join Zoom-Meeting
https://us06web.zoom.us/j/84307493968
Meeting-ID: 843 0749 3968